The Beatrice Hunter Cancer Research Institute logo
  • Dr. Kimberly Brewer, PhD

Appointments:

Research Scientist, Nova Scotia Health Authority

Staff Scientist, IWK Health Centre

Affiliations:

 Nova Scotia Health Authority, IWK Health Centre, Biomedical Translational Imaging Centre (BIOTIC)

Research Interests:

Molecular imaging, cancer immunotherapy, MRI, drug development

Using Molecular Imaging for the Development of Novel Cancer Therapeutics

There are hundreds of novel cancer therapeutics currently under development in North America. However, only 8% of drugs will make it all the way through clinical trials. Dr. Brewer is interested in using molecular imaging techniques, particularly magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) and single photon emission computed tomography (SPECT).

These imaging tools can be used to better understand novel therapeutics at the preclinical stage and to help develop novel biomarkers that will better represent the mechanisms induced by non-chemotherapeutic based cancer therapies, particularly immunotherapies. 

Involvement with BHCRI to date:

Dr. Kimberly Brewer is a BHCRI Associate Member

Phone:

902-470-6823

Contact:

1796 Summer Street, Suite 3900, Halifax, NS, B3H 3A7
Site by: Spectacle Group